Investing Ideas
/
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Value score of at least 4 focused on companies with a low market cap.

1 companies

Norda

Market Cap: NOK 436.7m

A biotechnology company, engages in the cancer diagnostic activities.

NORD

NOK 85.10

n/a